Chronic exposure to cannabinoids during adolescence causes long-lasting behavioral deficits in adult mice

Addict Biol. 2017 Nov;22(6):1778-1789. doi: 10.1111/adb.12446. Epub 2016 Aug 31.

Abstract

Regular use of marijuana during adolescence enhances the risk of long-lasting neurobiological changes in adulthood. The present study was aimed at assessing the effect of long-term administration of the synthetic cannabinoid WIN55212.2 during adolescence in young adult mice. Adolescent mice aged 5 weeks were subjected daily to the pharmacological action of WIN55212.2 for 3 weeks and were then left undisturbed in their home cage for a 5-week period and finally evaluated by behavioral testing. Mice that received the drug during adolescence showed memory impairment in the Morris water maze, as well as a dose-dependent memory impairment in fear conditioning. In addition, the administration of 3 mg/kg WIN55212.2 in adolescence increased adult hippocampal AEA levels and promoted DNA hypermethylation at the intragenic region of the intracellular signaling modulator Rgs7, which was accompanied by a lower rate of mRNA transcription of this gene, suggesting a potential causal relation. Although the concrete mechanisms underlying the behavioral observations remain to be elucidated, we demonstrate that long-term administration of 3 mg/kg of WIN during adolescence leads to increased endocannabinoid levels and altered Rgs7 expression in adulthood and establish a potential link to epigenetic changes.

Keywords: Adolescence; CA regions; DNA methylation and Rgs7; WIN55212.2; learning and memory.

MeSH terms

  • Animals
  • Behavior, Animal / drug effects*
  • Benzoxazines / pharmacology*
  • Brain / drug effects*
  • Cannabinoids / pharmacology
  • Disease Models, Animal
  • Male
  • Memory Disorders / chemically induced*
  • Mice
  • Mice, Inbred C57BL
  • Morpholines / pharmacology*
  • Naphthalenes / pharmacology*

Substances

  • Benzoxazines
  • Cannabinoids
  • Morpholines
  • Naphthalenes
  • (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone